The cost of medical weight loss programs featuring semaglutide in Tijuana, Mexico typically saves patients 60% to 80% compared to the United States and Canada
Here is a quick snapshot of where each medication stands: Tirzepatide (brand names: Mounjaro for diabetes, Zepbound for weight loss): Greater average weight loss in trials, dual receptor mechanism, no FDA-approved cardiovascular outcomes indication as of 2026 Semaglutide (brand names: Ozempic for diabetes, Wegovy for weight loss): Slightly lower average weight loss, single receptor mechanism, FDA-approved for reducing major cardiovascular events in patients with established heart disease Administration: Both are once-weekly injections
Why Meal Planning Matters More on GLP-1 Medications When your appetite drops significantly, the meals you do eat carry more weight
Unfortunately, after one year, weight loss between the two groups was not different
[DOI] [PubMed] [Google Scholar] 23.Plsson R, Patel UD